Literature DB >> 25510599

Lactosylated PLGA nanoparticles containing ϵ-polylysine for the sustained release and liver-targeted delivery of the negatively charged proteins.

Ping Zhou1, Tong An1, Chuan Zhao1, Yuan Li1, Rongshan Li1, Rui Yang1, Yinsong Wang2, Xiujun Gao3.   

Abstract

The acidic internal pH environment, initial burst release and lack of targeting property are main limitations of poly(lactide-co-glycolide) (PLGA) nanoparticles for carrying proteins. In this study, ϵ-polylysine (ϵ-PL) was used as an anti-acidic agent and a protein protectant to prepare PLGA nanoparticles for the protein delivery. To obtain the liver-targeting capability, lactosylated PLGA (Lac-PLGA) was synthesized by conjugation of lactose acid to PLGA at both ends, and then used to prepare nanoparticles containing ϵ-PL by the nanoprecipitation method. Bovine serumal bumin (BSA), a negatively charged protein, was efficiently loaded into Lac-PLGA/ϵ-PL nanoparticles and exhibited significant decreased burst release in vitro, sustained release in the blood and increased liver distribution in mice after intravenous injections. The enhanced stability of BSA was due to its electrical interaction with ϵ-PL and the neutralized internal environment of nanoparticles. In conclusion, Lac-PLGA/ϵ-PL nanoparticle system can be used as a promising carrier for the negatively charged proteins.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lactosylated PLGA; Nanoparticle; Protein; Sustained release; ϵ-Polylysine

Mesh:

Substances:

Year:  2014        PMID: 25510599     DOI: 10.1016/j.ijpharm.2014.12.017

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

Review 1.  Nanotechnology for protein delivery: Overview and perspectives.

Authors:  Mikyung Yu; Jun Wu; Jinjun Shi; Omid C Farokhzad
Journal:  J Control Release       Date:  2015-10-13       Impact factor: 9.776

2.  A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.

Authors:  Xun Yuan; Wenxiang Ji; Si Chen; Yuling Bao; Songwei Tan; Shun Lu; Kongming Wu; Qian Chu
Journal:  Int J Nanomedicine       Date:  2016-05-25

3.  Brain-targeted enzyme-loaded nanoparticles: A breach through the blood-brain barrier for enzyme replacement therapy in Krabbe disease.

Authors:  Ambra Del Grosso; Marianna Galliani; Lucia Angella; Melissa Santi; Ilaria Tonazzini; Gabriele Parlanti; Giovanni Signore; Marco Cecchini
Journal:  Sci Adv       Date:  2019-11-20       Impact factor: 14.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.